Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-687-1 | CAS number: 162303-51-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- sub-chronic toxicity: inhalation
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Comparable to guideline study. Read-across justification: The substance is hydrolytically unstable. When it comes in contact with water or moisture complete hydrolysis will take place with no significant reaction products other than alcohol and hydrated titanium dioxide. This rapid hydrolysis (hydrolysis half-life < 3 minutes to < 2 hours) is the driving force for the toxicokinetics of target substance. Because of the rapid hydrolysis, the influence of the mode of administration through inhalation, dermal and oral is related to the hazardous degradation product (alcohol) released from the target substance. The identification of degradation products from the hydrolysis study conducted for the target substance verifies that there are no impurities in the alcohol released from the target substance, which might change the hazardous properties of the target substance compared to the properties of the pure alcohol. As there is a mechanistic reasoning to the read-across, the unnecessary animal testing is avoided by using the read-across data from the degradation product (relevant alcohol) to evaluate irritation, sensitization and the short term and long-term toxicological effects and mutagenicity of the target substance.
Data source
Reference
- Reference Type:
- publication
- Title:
- Evaluation of subchronic toxicity of n-butyl acetate vapor
- Author:
- David, R.M., Tyler, T.R., Ouellette, R., Faber, W.D. and Banton, M.I.
- Year:
- 2 001
- Bibliographic source:
- Food and Chemical Toxicology 39, 877-886
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.2450 (90-Day Inhalation Toxicity)
- Deviations:
- yes
- Remarks:
- the tissues from the central and peripheral nervous systems were not examined histologically
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- N-butyl acetate
- EC Number:
- 204-658-1
- EC Name:
- N-butyl acetate
- Cas Number:
- 123-86-4
- IUPAC Name:
- butyl acetate
- Details on test material:
- - Name of test material (as cited in publication): nBA
- Analytical purity: 99.9% by GC
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Kingston, USA
- Age at study initiation: ca. 60 d
- Mean weight at study initiation: 271+-7 g (males); 215+-8 g (females); the variability in body weight of individual animals in the selected population did not exceed 20% of the mean for each sex
- Housing: individually in stainless-steel, wire-mesh cages
- Diet: Certified Rodent Diet ad libitum
- Water: filtered municipal tap water
ENVIRONMENTAL CONDITIONS
not reported
Administration / exposure
- Route of administration:
- inhalation: vapour
- Vehicle:
- air
- Details on inhalation exposure:
- The test atmosphere was generated by metering the test substance into glass distillation columns packed with glass beads. Filtered, compressed air was passed through the glass bead-packed columns to evaporate the test substance. The distillation columns were heated to approximately 50°C to enhance vaporization. The oxygen content of the chamber exposure atmosphere was at least 19.0%. The total airflow was set at 12–14 air changes per h. The temperature and humidity were maintained at 20.6–24.7°C and 36.7–68.7%, respectively.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Chamber vapor concentrations were determined at least once each hour with an infrared gas analyzer set at a wavelength of 3.38 µm.
- Duration of treatment / exposure:
- 6 h
- Frequency of treatment:
- 5d/week = 65 exposure days within 13 weeks
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
ca. 2.35, 7.05 and 14.1 mg/L
Basis:
analytical conc.
- Remarks:
- Doses / Concentrations:
500, 1500 and 3000 ppm
Basis:
analytical conc.
- No. of animals per sex per dose:
- 15
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: A concentration of 3000 ppm was selected as an exposure concentration that would produce overt signs of toxicity, and 500 ppm was selected as an exposure concentration that was expected to have no effect. An exposure concentration of 1500 ppm was selected as the intermediate exposure concentration (based on the results of a 2-week repeated exposure study in which animals were exposed to 0, 750, 1500 or 3000 ppm nBA).
Examinations
- Observations and examinations performed and frequency:
- OBSERVATIONS
Body weights and feed consumption were measured weekly prior to exposure. Animals were fasted the day prior to necropsy. Fasted body weights were measured after exsanguination, but prior to necropsy. This procedure is standard practice in the laboratory because it allows for blood collection from the posterior vena cava while the animal is under anesthesia, and reduces the variability in the ratio of body and organ weight due to differences in body fluids. Before and after exposure, each rat was removed from its cage and examined. Cageside observations were conducted once a day on weekends. Observations included, but were not limited to, examination of the hair, skin, eyes and mucous membranes, motor activity, feces, urine, respiratory system, circulatory system, autonomic nervous system, central nervous system, and behavior patterns.
HEMATOLOGY and CLINICAL CHEMISTRY
Animals were fasted beginning after their last exposure. The following day, animals were anesthetized with Metofane, and blood was collected from the posterior vena cava. The blood was placed into vacutainer tubes and allowed to clot for analyses of serum. Other tubes containing an anticoagulant were used for analyses of whole blood samples. Blood smears were also prepared for blood cell counts. Following blood collection, the animals were killed humanely by exsanguination under anesthesia. Animals were bled and euthanatized in random order based on a computer-generated list.
Whole blood samples were analyzed for red blood cell count, total white blood cell counts, hemoglobin, hematocrit and red blood cell indices using an hematology analyzer. Prothrombin time was measured using a Fibrosystems analyzer. Slides with blood smears were stained and examined for cellular morphology, differential white blood cell count and platelet count. Slides with blood smears were stained and examined for cellular morphology, differential white blood cell count and platelet count.
Serum samples were analyzed for total protein, total bilirubin, calcium, phosphorous, urea nitrogen, creatinine, glucose, gamma-glutamyltransferase, aspartate aminotransferase, alanine aminotransferase, sorbitol dehydrogenase and alkaline phosphatase using a serum analyzer. Albumin concentration and isozyme profile were determined using a Gel Electrophoresis System. The albumin/globulin ratio was calculated from total protein and albumin concentrations. Serum sodium and potassium concentrations were determined using a Photometer and serum chloride concentration was measured using a chloride Analyzer.
OPHTHALMOSCOPY
All rats were examined by a veterinarian for retinal and corneal lesions prior to the start of the study using a direct ophthalmoscope. During the last week of exposure, animals from the control and high-concentration groups were re-examined. Because no changes were detected in the eyes of the high-concentration animals, the animals from the low- and mid-concentration groups were not re-examined. - Sacrifice and pathology:
- After 13 weeks of exposure, animals were fasted overnight. The following day, animals were anesthetized with Metofane, and blood was collected from the posterior vena cava. The animals were then exsanguinated and weighed. Wet weights of the liver, kidneys, testes or ovaries, spleen, adrenal glands, lungs and brain were recorded for all animals at necropsy. Paired organs were weighed together, except for the testes, which were weighed individually. All tissues listed in the US EPA Health Effects Testing Guideline for Inhalation Toxicity (40 CFR 798.2450) were collected and preserved in 10% buffered formalin (pH 7.4). The capsule of the right testis was pricked with a 22-gauge needle and preserved in Millonig’s fixative (10% neutral buffered formalin with phosphate buffered saline, pH 7.4).
All tissues listed below were embedded in paraffin, sectioned at 5 mm, and stained with hematoxylin and eosin (H&E). The nasal passages were decalcified prior to being embedded and sectioned. The lungs were sectioned along a plane allowing visual examination of the major bronchi and bronchioles. The right testis was embedded in glycol methacrylate, sectioned, and stained with H&E and periodic Schiff’s reagent. All tissues except for the brain, spinal cord and peripheral nerve were examined microscopically from the control and high-concentration groups. Nervous tissue from animals exposed simultaneously was evaluated in the neurotoxicity study (CMA 1996b). The lungs, nasal passages, thymus (males only), stomach (females only) and gross lesions were examined from the mid- and low concentration groups. - Other examinations:
- The left testis and left epididymis of each male rat were placed into individual bags and frozen at -25°C for sperm counts. Samples were shipped to Research Triangle Institute (Research Triangle Park, NC, USA) for analysis. The frozen tissues were weighed to assess the effect of freezing, and homogenized according to the procedure described in Fail et al. (1991). The number of elongated spermatids (testes) or spermatozoa (epididymis) were counted. The results are expressed per gram tissue weight.
- Statistics:
- Body weight, feed consumption, serum chemistry, hematology, organ weight and sperm count data were evaluated using the following statistical tests: Bartlett’s test (P<=0.01), one-way analysis of variance (ANOVA) (P<=0.05), and Duncan’s multiple range test (P<=0.05) or Dunnett’s test to indicate statistical significance. If the Bartlett’s test indicated unequal variances, the data were evaluated using the Kruskal–Wallis H-test and the Mann–Whitney U-test.
A probability of P<=0.05 (two-tailed) was used to determine significance. If the Bartlett’s test indicated unequal variances, the data were evaluated using the Kruskal–Wallis H-test and the Mann–Whitney U-test.
Results and discussion
Results of examinations
- Details on results:
- MORTALITY
No mortality occurred in any of the treated groups during the study.
CLINICAL SIGNS
Animals exposed to 3000 ppm (ca. 14.1 mg/L) had reduced activity levels during exposure that were of generally minor severity. Reduced activity was defined as less movement, decreased alertness, and slower response to tapping on the chamber wall compared with activity levels exhibited by control animals. Signs of diarrhea and red discoloration on the chin hair were also observed. Animals exposed to 1500 ppm (ca. 7.05 mg/L) appeared normal for the first 5 h of day 0 and the first hour or two of days 1 and 2, then exhibited reduced activity of generally minimal severity for the remainder of the daily exposure periods. Reduced activity of minimal severity was generally seen throughout daily exposures thereafter. Control and 500 ppm (2.350 mg/L) animals appeared normal during exposure.
BODY WEIGHT and FOOD CONSUMPTION
Body weights for the 1500 and 3000 ppm groups (ca. 7.05 and 14.1 mg/L) were significantly lower than the control group for most of the study. Overall weight gains for the 3000 ppm group were 62 and 78% of weight gains for the control group (males and females, respectively), while overall weight gains for the 1500 ppm groups were 77 and 70% of the control group (males and females, respectively). Feed consumption for the 3000 ppm groups were significantly lower than for the control group throughout the study for male rats and at all intervals except days 84 and 91 for female rats. Mean feed consumption values for the 1500 ppm groups were significantly lower than the control group for the majority of the study, and sporadically lower for the 500 ppm groups compared with the control group.
CLINICAL CHEMISTRY and HEMATOLOGY
No effects considered as biologically relevant were observed.
No significant differences in hematologic parameters were seen after 30 days on test. Significantly higher mean erythrocyte counts, hemoglobin concentration and hematocrit values were observed for the 3000 ppm male and female rats after 90 days on test compared with the control groups . The mean eosinophil percentage formale 3000 ppm rats was also significantly higher than for the control group. All the values were within normal limits for rats of this age and for the age and strain of the animals used in this laboratory, and none of the differences were considered biologically significant.
After 30 days on test, mean sodium concentrations for the male and female 3000 ppm groups were significantly lower than for the control group. The differences were slight (ca. 1 Meq/L), however. The mean chloride concentration for the 1500 ppm male group was significantly lower compared with the control group. However, this difference was also small (< 4 Meq/L). No other differences in serum chemistries were seen among groups. After 90 days on test, mean albumin and total protein concentrations for the 3000 ppm female group were significantly lower than for the control group. Mean sorbitol dehydrogenase activity for the 1500 ppm male group was significantly higher than for the control group. These changes were not considered to be toxicologically meaningful, and no other differences in serum chemistry were observed among groups.
OPHTHALMOSCOPY
No treatment-related ophthalmologic changes were observed.
ORGAN WEIGHTS
Terminal body weights measured after exsanguination were significantly lower for the 1500 and 3000 ppm male and female groups compared with the control group. Absolute weights of the liver, kidneys and spleen reflect this reduced body weight. Liver and spleen weights for the 1500 and 3000 ppm male and female groups were significantly lower than for the control groups. Absolute kidney weights for the 1500 ppm female and 3000 ppm male and female groups were also significantly lower than for the control groups. However, relative organ weights (to body weight) for these organs were not significantly different with the exception of the spleen-to-body weight ratio for the 3000 ppm male group, which was significantly lower than for the control group.
Reduced body weight was also reflected in the significantly lower absolute brain weight for the 3000 ppm male group and significantly higher brain-to-body weight for the 1500 ppm female and 3000 ppm male groups compared with their respective control groups. In addition, testes-to-body weights for the 1500 and 3000 ppm male groups and the relative lung (to body weight) weight for the 3000 ppm male group were significantly higher than for the control group. Adrenal gland-to-body weight ratios for the 1500 ppm female and 3000 ppm male and female groups were significantly higher than for the respective control groups.
NECROPSY
Exposure-related changes were observed in the nasal passages and stomachs of 1500 and 3000 ppm rats. All male and female 3000 ppm rats and 4/10 male and 6/10 female 1500 ppm rats had necrosis of the olfactory epithelium. Degeneration of the olfactory epithelium was observed along the dorsal medial meatus. Degeneration and regeneration of the epithelium was seen along the third ethmoturbinate and several others. The lesion was characterized by karyorrhexis, pyknosis and depletion of olfactory epithelium cells. The severity of the olfactory lesion was mild to moderate for the 3000 ppm group and minimal to mild for the 1500 ppm group. Olfactory epithelium was replace in some areas by transitional or respiratory epithelium. A few (3/10) 3000 ppm female rats had acute inflammation and degenerative lesions (erosion) of the stomach mucosa (glandular vs forestomach). The severity was minimal to mild.
Lesions of this type in the stomach may be associated with swallowing of mucous containing the test substance, but due to the location of the lesion are more likely caused by stress (Glavin et al., 1991: The neurobiology of stress ulcers. Brain Research Reviews 16, 301–343). An occasional 3000 ppm male rat had atrophy of the thymus, but this was not considered to be a direct compoundrelated effect. Instead, this lesion was attributed to stress (Greaves and Faccini, 1992: Rat Histopathology, A Glossary for Use in Toxicity and Carcinogenicity Studies. p. 51. Elsevier Science, Amsterdam).
SPERM COUNTS
No dose-related or statistically significant effect on epidydimidal or testicular sperm count was observed compared with controls, although the epididymidal sperm counts for all treated groups were lower than controls.
Effect levels
- Dose descriptor:
- NOAEL
- Remarks:
- local and systemic
- Effect level:
- ca. 2.35 mg/L air (analytical)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: corresponding to 500 ppm; based on reduced body weight, food consumption and transient CNS effects; signs of necropsy of the olfactory epithelium
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Read-across justifications and data matrices are presented in IUCLID section 13.
Applicant's summary and conclusion
- Conclusions:
- The repeated dose inhalation toxicity study conducted using n-butyl acetate, the metabolic precursor of n-butanol, provides surrogate data for n-butanol. The NOAEL for n-butyl acetate is considered to be 2.35 mg/l. This NOAEL corresponds to 1.52 mg n-butanol /l (corrected for molecular weight).
- Executive summary:
The repeated dose inhalation toxicity study conducted using n-butyl acetate, the metabolic precursor of n-butanol, provides surrogate data for n-butanol. Rats (15/sex/dose level) were exposed to vapor concentrations of 0, 2.35, 7.05, 14.1 mg/l n-butyl acetate (i.e. 0, 500, 1500 and 3000 ppm) for 6 hours per workday during 13 weeks. Rats exposed to 7.05 mg/l and 14.1mg/l n-butyl acetate for 13 weeks decreased body weight, decreased weights of certain organ weights, decreased feed consumption were observed. However, no systemic, organ-specific toxicity was observed. Minimal, transient narcosis and sedation effects were also observed in rats exposed to 7.05 mg/l and 14.1 mg/l n-butyl acetate during exposure. No cumulative effect on activity during the 13-week exposure was observed. Thus, the NOAEL for n-butyl acetate is considered to be 2.35 mg/l. The NOAEL of 2.35 mg/l for n-butyl acetate corresponds to 1.52 mg n-butanol /l (corrected for molecular weight).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.